Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir
In: Clinical Infectious Diseases, 2014, vol. 59, no. 10, p. 1420-1428
Ajouter à la liste personnelle